Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director Declaration

11th Mar 2011 14:52

RNS Number : 8152C
United Drug PLC
11 March 2011
 

United Drug plc

Director Declaration

 

Further to the announcement by United Drug plc (the 'Company'), on 8 March 2011 which noted that Ms. Annette Flynn had stepped down as an Executive Director and had been appointed as a Non-Executive Director of the Company, the Company hereby notifies the following pursuant to paragraph 6.6.7 of the Irish Stock Exchange Listing Rules and 9.6.13 of the UK Listing Authority Listing Rules:

 

(a) Ms. A. Flynn was formerly an Executive Director of United Drug plc. Ms. A. Flynn has not held any other directorships in any other publicly quoted company in the past five years; and 

 

(b) there are no details requiring disclosure for Ms. A. Flynn under paragraph 6.6.7 (2) to (6) of the Irish Stock Exchange Listing Rules or under paragraph 9.6.13 (2) to (6) of the UK Listing Authority Listing Rules.

 

In addition, in fulfilment of any obligation imposed by Section 53 (1) of the Companies Act, 1990, Ms. A. Flynn has notified the Company that she currently has a beneficial interest in 184,733 ordinary shares in the Company and no longer holds any share options over ordinary shares in the share capital of the Company.

 

Ends 11 March 2011

 

 

For reference:

Karen Geoghegan 

Company Secretary

Tel: +353-1-4637720

 

About United Drug plc

 

Listed on the Stock Exchanges in London and Dublin, United Drug is a leading international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in the UK, Ireland, the Netherlands, Belgium, Sweden and the USA. 

 

The Company operates across three divisions, Contract Sales & Marketing Services, Healthcare Supply Chain and Packaging & Speciality Services.

 

In the Contract Sales & Marketing Services division, United Drug is the leading provider of contract sales outsourcing to pharmaceutical manufacturers in the UK and Ireland and has a growing presence in the US market. United Drug also provides related marketing services to pharmaceutical manufacturers in each of these markets.

 

In Healthcare Supply Chain, United Drug is the largest pharmaceutical wholesaler in the island of Ireland. It is also the market leader in contract distribution outsourcing (pre-wholesaling) in Ireland and has achieved the No. 1 position in the UK through its joint venture business, UniDrug Distribution Group (UDG). The Company provides specials medicines manufacturing and distribution services in the UK. Through its medical & scientific operations, United Drug provides sales & marketing and technical service solutions, including contract distribution services to a wide range of medical & scientific equipment & consumable manufacturers, and has a leading market position in Ireland and an emerging presence in the UK.

 

In the Packaging & Speciality division United Drug is a leading international provider of pharmaceutical contract packaging services, with facilities in the US, UK and Dutch and Belgian markets. The Company also provides speciality distribution and homecare services in the UK and Ireland.

For more information go to www.united-drug.ie 

 

 

This announcement has been issued through the Companies Announcement Service of

The Irish Stock Exchange.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNZFLFFFXFZBBE

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00